Etomidate Powder — Complete Research Overview

Etomidate is a short-acting intravenous anaesthetic compound first synthesised in 1964 by Janssen Pharmaceutica in Belgium. It belongs to the imidazole class of compounds and is characterised by its rapid onset and short duration of action making it a subject of significant interest in pharmacological and anaesthesia research. Etomidate Powder is the raw compound form of etomidate supplied as a fine white crystalline powder with 99.9% purity verified by HPLC laboratory testing. It is one of the most studied anaesthetic compounds in modern pharmacological research due to its unique mechanism of action and favourable cardiovascular stability profile compared to other anaesthetic agents.

Etomidate was first synthesised in 1964 and introduced into clinical research in the 1970s. It became a significant subject of study due to its ability to produce anaesthesia with minimal impact on cardiovascular function — a property that made it particularly interesting to researchers studying anaesthetic compounds in patients with compromised cardiac function. Research into etomidate expanded significantly through the 1980s and 1990s as scientists investigated its mechanism of action at the GABA-A receptor. Studies demonstrated that etomidate enhances the effect of GABA at the GABA-A receptor by binding to specific beta subunits — a discovery that contributed significantly to the broader understanding of anaesthetic mechanisms at the molecular level. Further research explored etomidate's suppression of adrenocortical function, specifically its inhibition of 11-beta hydroxylase — an enzyme involved in cortisol synthesis. This property has made etomidate a valuable research tool for scientists studying adrenal function, cortisol synthesis pathways and related endocrine research. Today etomidate remains one of the most researched anaesthetic compounds in pharmacology with ongoing studies exploring its structure-activity relationships and potential applications in anaesthesia research.

Etomidate Powder should be stored in a cool dry place away from direct sunlight and moisture. Recommended storage temperature is between 2°C and 8°C for long term preservation. Keep container tightly sealed when not in use. Store away from incompatible materials including strong oxidising agents. Proper storage conditions maintain compound integrity and purity over extended periods. Shelf life is approximately 2 years when stored correctly under recommended conditions.

Available to Order

In Stock